2026 Program

2026 Annual Scientific Meeting Program

Select the dates below to expand the program schedule. Schedule information is subject to change. Additional faculty details to be added as invitations are accepted. Last updated 20 June 2025.

Wednesday, 4 February 2026

Thursday, 5 February 2026

Time		Session Description
7:45 - 8:45 a.m.	Breakfast and Industry Symposium
9:00 - 10:00 a.m.	HCC: The Systemic-LRT Therapeutic Interface (300 Level Education) Moderated by Robert J. Lewandowski, MD, FSIR New Paradigms of HCC Management: Personalized Treatments and Therapeutic Hierarchy, presented by Alessandro Vitale, MD, PhD Pushing the Clinical Boundaries Toward Curative Therapies, presented by Edward Kim, MD, FSIR Timing of Transarterial and Systemic Therapies presented by Marina Baretti, MD What is the Role of Ablation in Metastatic Disease? presented by Franco Orsi, MD
10:15 - 11:15 a.m.	Emerging Soft Tissue Tumor Problems (200 Level Education) Moderated by Brian Welch, MD, and Nicole A. Lamperello, MD Neuroanatomic Considerations in Soft Tissue Ablation, presented by Anil Nicholas Kurup, MD Treatment of Desmoid Tumors: Drugs and Beads, presented by Joseph Erinjeri, MD, PhD Desmoid / Fibromatosis Ablation / Cryo Desmo Approach, presented by Uei Pua, MBBS, FRCR, MMed, FAMS, FCIRSE, FSIR, FSCAI, FACC Size Doesn't Matter: Ablating Large Volume and Problem Location Sarcomas, presented by Jonathan M. Morris, MD
10:15 - 11:15 a.m.	TME and Intratumoral Therapy (300 Level Education) Moderated by Nadine Abi-Jaoudeh, MD, and Terence P. Gade, MD, PhD Understanding the Tumor Microenvironment, presented by Nadine Abi-Jaoudeh, MD Rationale for Intratumoral Injection and Immunomodulators, presented by Gosse Adema, PhD Tumor Specific Scenarios for Intratumoral Injection: Pancreas to Melanoma, presented by Eric Wehrenberg-Klee, MD Practical Implementation [and Cases] in Percutaneous Anti Tumoral Treatments, presented by Rahul A. Sheth, MD Closing Discussion, facilitated by Rahul A. Sheth, MD
11:30 a.m. - 12:30 p.m.	IO and AI: Solving Problems or Creating Them? (300 Level Education) Moderated by Julius Chapiro, MD, PhD, and Joseph Erinjeri, MD, PhD Keynote: AI in IO, presented by Dania Daye, MD, PhD Foundational Models for AI in IO, presented by Bradford J. Wood, MD Potential Harms in the Use of AI in IO, presented by Judy Gichoya, MD, FSIRM Preoperative Lung Ablation Using AI, presented by Krishna Nand Keshava Murthy, MD Roundtable Discussion
11:30 a.m. - 12:30 p.m.	Ablation Planning, Confirmation & Guidance Workshop (Part 1) Sponsored by NEUWAVE Moderated by Bruno C. Odisio, MD, PhD, FSIR, FCIRSE, and Iwan Paolucci, PhD, and Milan N. Patel, MD Current Evidence for Ablative Margins: What Should We Know in 2025, presented by Prof. Marco Calandri, MD Impact of Proper Planning on Patient Selection, presented by Edward W. Johnston, BSc, MB ChB, PhD, FRCR, EBIR, FCIRSE Tips and Tricks for Ablation Confirmation in Clinical Practice, presented by Christiaan Overduin, PhD What is Missing in Planning and AC Space, presented by Iwan Paolucci, PhD
12:45 - 1:45 p.m.	Lunch Symposia
2:00 - 3:30 p.m.	Lung Tumor Board (200 Level Education) Moderated by Damian E. Dupuy, MD, FACR, and Stephen Solomon, MD Oncologist Perspective: Scenarios Where IR Locotherapy Would be Welcomed, presented by Vamsidhar Velcheti, MD Surgical Perspective: Scenarios where IRLocotherapy Would be Welcomed, presented by Michael Lanuti, MD Scenarios in Which IR Locotherapies Would be Welcomed: The Rad-Onc Perspective, presented by Dawn Owen, MD, PhD Case Discussions, facilitated by Rob Suh, MD
2:00 - 3:30 p.m.	Ablation Planning, Confirmation & Guidance Workshop(Part 2) Sponsored by NEUWAVE Moderated by Bruno C. Odisio, MD, PhD, FSIR, FCIRSE, and Iwan Paolucci, PhD Sterotactic and Robotics in Ablation - A Brief Overview of Clinical Applications and Current Evidence, presented by Marie Beerman, MD Hands On, All Faculty
3:30 - 4:30 p.m.	Discovery Theatre Presentations: Young IO Research Investigator Awardee Presentations and Late Breaking Abstracts
3:30 - 4:30 p.m.	Exhibit Hall Networking
4:30 - 5:30 p.m.	President's Welcome & State of IO
3:30 - 7:00 p.m.	Exhibit Hall
5:30 - 7:00 p.m.	SIO 2026 Welcome Reception in the Exhibit Hall

Friday, 6 February 2026

Time		Session Description
7:45 a.m. - 6:30 p.m.	Exhibit Hall
7:45 - 8:45 a.m.	Exhibit Hall & Breakfast Symposia
9:00 - 10:00 a.m.	Dr. Sidney Wallace and Dr. Michael J. Wallace Distinguished Lecture Presented by Afshin Gangi, MD, PhD
10:15 - 11:15 a.m.	Scientific Oral Abstracts (200 Level Education) Precision in Practice: Evolving Applications of y90 in Primary and Metastatic Liver Disease Moderated by Ryan Hickey, MD, FSIR and Armeen Mahvash, MD Current state of Radiation Segmentectomy presented by Ryan Hickey, MD, FSIR Ideal Patient Selection for Intermediate State HCC Review of data for y90 in metastatic disease presented by Armeen Mahvash, MD Review of Challenging cases for y90 Discussion
11:30 a.m. - 12:30 p.m.	HCC Tumor Board (200 Level Education) Moderated by Sarah White, MD, MS, and Beau Bosko Toskich, MD, FSIR Laura Crocetti, MD, PhD Alessandro Vitale, MD, PhD Marina Baretti, MD Riad Salem, MD, MBA Jin Woo Choi, MD, PhD Pretesh R. Patel, MD
12:30 - 12:45 p.m.	Industry Product Theatre
12:45 - 1: 45 p.m.	Exhibit Hall & Lunch Symposia
1:45 - 2:00 p.m.	Industry Product Theatre
2:00 - 3:00 p.m.	Critical Studies (200 Level Education) Moderated by Edward Kim, MD, FSIR, Terence P. Gade, MD, PhD, and Philippe L. Pereira, MD RETNET: Driving a Study to Completion and Implications, presented by Michael C. Soulen, MD, FSIR, FCIRSE ACCLAIM: Where Are We? presented by Constantinos Sofocleous, MD, PhD, FSIR, FCIRSE CHOPIN: Closing Out a Study and Findings, presented by Mark Burgmans, MD, PhD COVERALL: Delivering a Study with Difficult Concepts, presented by Bruno C. Odisio, MD, PhD, FSIR Cryoablation in Metastatic Melanoma: Development and Findings in a Fundamental Study, presented by Florian J. Fintelmann, MD ENFORCE: What to Test and How in Prostate Cancer, presented by Jurgen Futterer, MD, PhD Emerald Pipeline: 1/3/Y90, presented by Joseph Erinjeri, MD, PhD
2:00 - 3:00 p.m.	GU Session (200 Level Education) Moderated by David Woodrum, MD, PhD Prostate Cancer: Treatment Decision Making, presented by Timothy McClure, MD, MS Anatomic Considerations in Focal Treatment, presented by Guilherme Mariotti, MD, MSc, PhD, MBA Focal Treatment in Prostate: The Best Way to Do It, presented by David Woodrum, MD, PhD Renal Cancer Ablation: What is the Current Place of Ablation and Have We Agreed a Standardized Procedure? presented by Christos Georgiades, MD, PhD Roundtable Discussion: Challenging Cases, facilitated by Alex King, MBBS, FRCR
2:00 - 6:00 p.m.	y90 Dosimetry & Hands-on Workshop Introductory Lectures, moderated by Irene Bargellini, MD y90 Dosimetry Made Easy: What IRs Need to Know, presented by Marnix Lam, MD, PhD y90 Dosimetry: Current Guidelines in Primary Liver Lesions, presented by Siddharth A. Padia, MD y90 Dosimetry: Current Guidelines in Liver Metastases, presented by Ammar Sarwar, MD FSIR The Importance of Spheres' Concentration and Distribution: presented by Tyler Sandow, MD Case 1: Radiation Segmentectomy, presented by Siddharth A. Padia, MD Case 2: Radiation Lobectomy, presented by Zachary Berman, MD Case 3: Multifocal Liver Mets, presented by Roberto Iezzi, MD, FCIRSE
3:30 - 4:30 p.m.	Exhibit Hall Networking
3:30 - 4:30 p.m.	Discovery Theatre Publishing in Interventional Oncology Moderated by Michael C. Soulen, MD, FSIR, FCIRSE and Riad Salem, MD, MBA Publishing in the IO Space: The View from CVIR Oncology, Mark Burgmans, MD, PhD Publishing in the IO Space: How Should SIO Proceed?, Daniel Sze, MD, PhD Discussion Industry Product Theatre
4:30 - 5:30 p.m.	Grants Session (300 Level Education) Moderated by Terence P. Gade, MD, PhD, Julius Chapiro, MD, PhD, and Christopher D. Malone, MD Welcome and SIO Grant Program Introduction, presented by Terence P. Gade, MD, PhD Understanding the Influence of Hepatocellular Carcinoma Tumor Immune Microenvironment on Response to y-90 Radioembolization and Potential Combinations with Immune Checkpoint Inhibition, presented by Christopher D. Malone, MD Development of a Next-Generation Drug Delivery System Utilizing Lipiodol in Combination with Immune Checkpoint Inhibitors in Hepatocellular Carcinoma presented by Toshiro Tanaka, MD, PhD Discussion
5:30 - 6:30 p.m.	Science and Sips ePoster Reception

Saturday, 7 February 2026

Time		Session Description
7:45 a.m. - 3:00 p.m.	Exhibit Hall
7:45 - 8:45 a.m.	Breakfast & Industry Symposium Optimal Preparation and Treatment Endpoints in cTACE Moderated by Sara White, MD, MS Hands on demonstrations Michael Soulen, MD, FSIR, FCIRSE Nicholas Fidelman, MD Irene Bargellini, MD, Prof Nishita Kothary, MD Juan Gimenez, MD William S. Rilling, MD, FSIR Tyler Sandow, MD Nadine Abi-Jaoudeh, MD Gregory Nadolski, MD Robert Lewandowski, MD, FSIR Daniel Sze, MD, PhD Kashayar Farsad, MD, PhD Zach Berman, MD Julius Chapiro, MD, PhD
9:00 - 10:00 a.m.	SIO Meets SITC: Beyond Liver (300 Level Education) Moderated by Rony Avritscher, MD, FSIR, and Tulia C. Bruno, PhD Immunoscoring and TLS as a Biomarker of Response to Local Therapy presented by Tullia C. Bruno, PhD Local Approaches Overcoming Barriers in CAR-T Cell Delivery presented presented by Neil Sheppard, D.Phil Development and Applications of Personalized Antitumoral Approaches presented by Dr. Catherine Ju-Ying Wu, MD Consideration for Stromal Imaging Biomarkers During Locoregional Treatments presented by Rony Avritscher, MD, FSIR Biomarkers of Tumor Microenvironment Barriers in Endovascular Therapy presented by Adam Stevens, PhD
10:15 - 11:15 a.m.	OMD Tumor Board [Non-Hepatic] (200 Level Education) Moderated by Alexis Kelekis, MD, PhD, FCIRSE, FSIR, and David Breen, MD, FRCR Alda Tam, MD Robert Liddell, MD Alexandra Hotca-Cho, MD Dimitrios Filippiadis, MD, PhD, MSc, EBIR Michael Rutenberg, MD, PhD
10:15 - 11:15 a.m.	Emerging Non-Thermal Ablation: Clinical Applications (300 Level Education) Moderated by Paul Laeseke, MD, PhD, and Marwan Moussa, MD Limitations of Thermal Ablation, presented by Erica Knavel Koepsel, MD IRE: Role in Cancer Care, presented by Man-Deuk Kim, MD, PhD, FSIR Current Status, Data, and Limitations of Histotripsy, presented by Mishal Mendiratta-Lala, MD Electrochemotherapy in Palliation, presented by Roberto Luigi Cazzato, MD, PhD PEF in Advanced Lung Cancer: Where are We? presented by William Moore, MD
11:30 a.m. - 12:30 p.m.	Scientific Oral Abstracts (200 Level Education)
11:30 a.m. - 12:30 p.m.	Locally Advanced Pancreatic Cancer: Adding the Local Approach (300 Level Education) Presented by William S. Rilling, MD, FSIR, and Govindarajan Narayanan, MD, FSIR State of the Art Optimal Chemotherapy [mFolfirinox / Gem-nabPac] and Radiotherapy Consolidation presented by Maria Pia Morelli, MD, PhD Understanding the Difficult TME of LAPC, presented by Nadine Abi-Jaoudeh, MD IRE, Panfire-2 and Crossfire: What Have We Learned? presented by Hester J. Scheffer, MD Emerging Locoregional Technologies and Energies, presented by Martijn R. Meijerink, MD, PhD, FCIRSE Adjunctive Intra-arterial Approaches, presented by Paula Novelli, MD, FSIR
12:30 - 12:45 p.m.	Industry Product Theatre
12:45 - 1:45 p.m.	Exhibit Hall & Lunch Symposia
1:45 - 2:00 p.m.	Industry Product Theatre
2:00 - 3:00 p.m.	Discovery Theatre - Abstract Presentations
3:00 - 4:30 p.m.	Metastatic Liver Session: mCRC and mNET (200 Level Education) Moderated by Nicholas Fidelman, MD, and Constantinos Sofocleous, MD, PhD, FSIR, FCIRSE mNET: Intersociety Guideline Update presented by Nicholas Fidelman, MD mNET: Current Role of y90? presented by Ghassan El-Haddad, MD Assessment of FLR Function: How? presented by David C. Madoff, MD Optimal Strategies for Venous Deprivation? presented by Jose Hugo Luz, MD, PhD, SOBRICE, FCIRSE, EBIR In Light of COLLISION: Optimal Approach to Bilobar Disease - IR Perspective, presented by Martijn R. Meijerink, MD, PhD In Light of COLLISION: Optimal Approach to Bilobar Disease - Surgeons Perspective Cases, presented by Kevin Soares, MD, MS
3:00 - 4:30 p.m.	Metastatic Bone and Soft Tissue Malignancy: Navigating the Multidisciplinary Landscape (200 Level Education) Moderated by Jack Jennings, MD, PhD and Steven Yevich, MD, MPH Critical Role of Surgical Oncology, presented by Matthew Goodwin, MD, PhD State of the Art Palliative Radiation and SBRT Presented by Meena Bedi, MD, MS IR Role in the Multidisciplinary Treatment, presented by Matthew Callstrom, MD, PhD Multidisciplinary Tumor Board, moderated by Jack Jennings, MD, PhD and Steven Yevich, MD, MPH, with Matt Goodwin, MD, PhD, and Matthew Callstrom, MC
7:00 - 10:00 p.m.	Saturday Soiree Social Event* Additional registration required

Sunday, 8 February 2026

Time	Session Description
9:00 - 10:30 a.m.	Private Practice Forum: New Arenas (200 Level Education) Moderated by Jason R. Levy, MD, FSIR, and Juan C. Camacho, MD Business Case to Clients and Strategy for Building IO in the Hospital Based Setting, presented by Jason R. Levy, MD, FSIR Business Case for Building IO in an OBL Setting, presented by Charles Nutting, DO, FSIR Business Case for Building Full Service IO in an OBL Setting as a Part of a DR/IR Group Thyroid Ablation for Primary Thyroid Cancer, presented by Juan C. Camacho, MD Breast Cryoablation: Current Indications and Technical Updates and Payment Models, presented by Kenneth Tomkovich, MD, FSIR Roundtable Discussion
10:45 a.m. - 12:15 p.m.	Evidence-Based Illustrative Case Review (200 Level Education) Moderated by Nicholas Fidelman, MD, Roberto Luigi Cazzato, MD, PhD, and Charles Y. Kim, MD Case 1: Lymphatics, presented by Saebeom Hur, MD, PhD Case 2: Thyroid, presented by Wei-Che Lin, Prof, MD, PhD Case 3: Difficult mCRC, presented by Stephen Hunt, MTR, MD, PhD, FSIR Case 4: Adrenal, presented by Ahmad Parvinian, MD Case 5: Sarcoma / Soft Tissue, presented by Roberto Luigi Cazzato, MD, PhD Case 6: Vascular Emergencies in IO, presented by Charles Y. Kim, MD Case 7: T1b RCC, presented by AJ Gunn, MD

Specialty Programming Opportunities

IO Essentials

IO Essentials is designed specifically for medical students, fellows, residents, and early career IO practitioners. Apply to join our cohort of IO Essentials scholars, and take advantage of content and networking opportunities developed just for you! IO Essentials programming will take place on Thursday, Friday, and Saturday.

Learn More

Wednesday, 4 February 2026

Palliative Pain in Cancer Patients Master Class

From foundational evaluation to advanced procedural techniques, this course covers the full spectrum of pain management — including nerve ablation, neurolysis, intrathecal pumps, and spinal cord stimulation — with an emphasis on evidence-based practices.

Learn More

RISE Forum

SIO aims to advance the levels of evidence in interventional oncology (IO), supporting access to preclinical and clinical research efforts with this six-hour program, hosted on Wednesday, 4 February 2026. This innovative research forum will be the first of its kind to be organized by a major radiology society.

Learn More